Search

Combining drugs is an efficient tool in fighting bacterial infections. It has been proven to enable an increased antimicrobial activity compared to mono‐drug therapies. Current commercial dressings for treatment of infected wounds provide delivery of one drug only. Therefore, there is an obvious need to develop a technology enabling incorporation and release of two and more actives. Ideally, such technology should prevent potential cross‐reactions between the drugs during long‐term storage. Here, a concept of drug compartmentalization within distinct glycerol domains of glycerol‐silicone elastomer membranes is presented. Multiple drugs are encapsulated within different types of glycerol domains hampering any cross‐reactions. The drugs are simultaneously released upon contact with aqueous media and the release kinetics can be precisely adjusted by tuning various material parameters, such as glycerol content and membrane thickness. Ultimately, the drug release capabilities and the antimicrobial potential are evaluated against a variety of bacteria in an agar diffusion assay. The membranes are proven effective against different bacterial species, which confirms the efficiency of release even at minimum moisture levels. The glycerol‐silicone platform technology enables delivery of virtually unlimited combinations of drugs from different drug families (e.g., antimicrobial, anti‐inflammatory, and pain relief agents) facilitating new ways of treating wound disorders. [ABSTRACT FROM AUTHOR]